2 active not recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
Follow Down Syndrome: new trials by email Literature Review of Down Syndrome trials Research Report on Down Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome Atomoxetine and Oxybutynin (ato-oxy) - Obstructive Sleep Apnea, Down Syndrome | Phase 2 | Active not recruiting | University of Arizona | 36 | 2023-09-29 | 2026-04-07 |
| ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016 Daunorubicin, Prednisolone, Vincristine - Down Syndrome, Acute Lymphoblastic Leukemia | Phase 2 | Active not recruiting | National Hospital Organization Nagoya Medical Center | 60 | 2017-04-18 | 2026-05-11 |
Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Sleep Apnea, Obstructive (1)
Abnormalities, Multiple (2) · Chromosome Disorders (2) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Intellectual Disability (2) · Nervous System Diseases (2) · Neurobehavioral Manifestations (2) · Neurologic Manifestations (2) · Apnea (1) · Dyssomnias (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1)
Atomoxetine Hydrochloride (1) · Cyclophosphamide (1) · Cytarabine (1) · Daunorubicin (1) · Epirubicin (1) · Hydrocortisone (1) · Mercaptopurine (1) · Methotrexate (1) · Prednisolone (1) · Vincristine (1) · oxybutynin (1) · prednylidene (1)
National Hospital Organization Nagoya Medical Center (1) · University of Arizona (1)
Hong Kong (1) · Japan (1) · Malaysia (1) · Singapore (1) · Taiwan (1) · Thailand (1) · United States (1)
Allen Yeoh, MBBS (1)
R33HL151254 (1)